SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001367644-14-000016
Filing Date
2014-03-10
Accepted
2014-03-10 16:09:14
Documents
17
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1881487
2 exhibit10-2.htm EX-10.HTM 45482
3 exhibit10-26.htm EX-10.26 79625
4 exhibit10-27.htm EX-10.27 26236
5 exhibit12.htm EX-12.1 46974
6 exhibit21.htm EX-21 13690
7 exhibit23.htm EX-23.1 5780
8 exhibit31-1.htm EX-31.1 12639
9 exhibit31-2.htm EX-31.2 12607
10 exhibit32-1.htm EX-32.1 4567
11 exhibit32-2.htm EX-32.2 4532
  Complete submission text file 0001367644-14-000016.txt   12111136

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT ebs-20131231.xml EX-101.INS 1818946
13 XBRL TAXONOMY EXTENSION SCHEMA ebs-20131231.xsd EX-101.SCH 58165
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20131231_cal.xml EX-101.CAL 85360
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20131231_def.xml EX-101.DEF 361050
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20131231_lab.xml EX-101.LAB 993075
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20131231_pre.xml EX-101.PRE 600061
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33137 | Film No.: 14680962
SIC: 2834 Pharmaceutical Preparations